The article focuses on the implication of healthcare reform on medical device companies in the U.S. The companies predict the future effects of the reform's 2.3% excise tax starting in 2013. It predicts that small companies just above the threshold of less than five million dollars revenue will hurt the most. It points out that medical device industry will be suspicious of its position in the global market.